How to cite this article
Nascimento CR, Mendes R, Botelho Filho CAL, Barbosa RHA, Tenório PP. . Arq. Bras. Cardiol. 2023;120(5):e20220859.
Nascimento, Cristian Rodrigues do; Mendes, Rodrigo; Botelho Filho, Carlos Alberto de Lima; Barbosa, Romero Henrique de Almeida; Tenório, Pedro Pereira. . Arq. Bras. Cardiol., v. 120, n. 5, e20220859, May. 2023.
Nascimento, C. R. , Mendes, R., Botelho Filho, C. A. L., Barbosa, R. H. A., & Tenório, P. P. (2023). . Arq. Bras. Cardiol., 120(5), e20220859.
Nascimento, Cristian Rodrigues do and Mendes, Rodrigo and Botelho Filho, Carlos Alberto de Lima and Barbosa, Romero Henrique de Almeida and Tenório, Pedro Pereira. . Arq. Bras. Cardiol. [online]. 2023, vol. 120, n. 5, [cited 2025-09-07], e20220859. Available from: <https://abccardiol.org/en/article/12253/>. ISSN 0066-782X.
Figure 1
Dyslipidemia as a central element in atherosclerotic cardiovascular disease. ASCVD: atherosclerotic cardiovascular disease; LDL-C: low-density lipoprotein cholesterol. Limitations of statin-based therapy (non-exhaustive) include suboptimal LDL-C goal attainment, statin-associated adverse effects that may affect adherence, and potential drug interactions. Residual risk reflects the involvement of multiple underlying pathways.